ALCAM and neoplasm: Additionally, the relatively equal distribution of male patients’ tumors exhibiting low vs. high CD166 tumor expression (38.3% vs. 40%, respectively) was most probably related to the limited number of investigated cases and the gender distribution in our study group, which was due to the accessibility of patients during the period of investigation.